NTF3 and colorectal carcinoma: Current studies report that NT-3 and TrkC expression was significantly elevated in normal colon tissues than in primary CRC tissues and CRC cells but NT-3 treatment of colon cancer cells ectopically expressing TrkC inhibits the tumor suppressor activity of TrkC.